MedTrace Logo

Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely

NCT06597071 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-03-11

No results posted yet for this study

Summary

This is an observational longitudinal study in 4 cohorts of patients with Parkinsonian syndromes, who are visiting the Movement Disorders outpatient clinics.

The aim of the study is to assess the difference of oculometric measures in different neurodegenerative brain conditions and their accuracy over time, and as compared to clinical diagnosis, in order to find a change over time, difference between subgroups and correlations with accepted clinical endpoints in subjects who meet the inclusion criteria and who provide a signed Informed Consent.

Conditions

Interventions

OTHER

NeuraLight PD

NeuraLight software-based platform for PD patients

OTHER

NeuraLight PSP

NeuraLight software-based platform for PSP patients

OTHER

NeuraLight MSA

NeuraLight software-based platform for MSA patients

OTHER

NeuraLight

NeuraLight software-based platform

Sponsors & Collaborators

  • Hospitales Universitarios Virgen del Rocío

    collaborator OTHER

  • NeuraLight

    lead INDUSTRY

Principal Investigators

  • Pablo Mir, MD · IBIS (Instituto de Biomedicina de Sevilla), Calle Antonio Maura Montaner, Seville, Spain

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-10
Primary Completion
2025-10-01
Completion
2025-12-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06597071 on ClinicalTrials.gov